Oncolytics Biotech Stock Gross Profit
ONCY Stock | USD 1.17 0.05 4.46% |
Oncolytics Biotech fundamentals help investors to digest information that contributes to Oncolytics Biotech's financial success or failures. It also enables traders to predict the movement of Oncolytics Stock. The fundamental analysis module provides a way to measure Oncolytics Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oncolytics Biotech stock.
Last Reported | Projected for Next Year | ||
Gross Profit | -403 K | -423.1 K | |
Gross Profit Margin | 0.00 | 0.00 |
Oncolytics | Gross Profit |
Oncolytics Biotech Company Gross Profit Analysis
Oncolytics Biotech's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Oncolytics Biotech Gross Profit | (423.2K) |
Most of Oncolytics Biotech's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oncolytics Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Oncolytics Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Oncolytics Biotech is extremely important. It helps to project a fair market value of Oncolytics Stock properly, considering its historical fundamentals such as Gross Profit. Since Oncolytics Biotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Oncolytics Biotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Oncolytics Biotech's interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition |
Oncolytics Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oncolytics Biotech's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oncolytics Biotech could also be used in its relative valuation, which is a method of valuing Oncolytics Biotech by comparing valuation metrics of similar companies.Oncolytics Biotech is currently under evaluation in gross profit category among related companies.
Oncolytics Biotech Current Valuation Drivers
We derive many important indicators used in calculating different scores of Oncolytics Biotech from analyzing Oncolytics Biotech's financial statements. These drivers represent accounts that assess Oncolytics Biotech's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Oncolytics Biotech's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 137.6M | 122.4M | 94.8M | 128.1M | 118.2M | 137.4M | |
Enterprise Value | 124.0M | 91.6M | 54.2M | 116.8M | 87.1M | 118.3M |
Oncolytics Fundamentals
Return On Equity | -1.03 | ||||
Return On Asset | -0.55 | ||||
Current Valuation | 49.98 M | ||||
Shares Outstanding | 75.42 M | ||||
Shares Owned By Insiders | 3.90 % | ||||
Shares Owned By Institutions | 6.76 % | ||||
Number Of Shares Shorted | 928.07 K | ||||
Price To Earning | (2.06) X | ||||
Price To Book | 4.27 X | ||||
EBITDA | (33.39 M) | ||||
Net Income | (27.75 M) | ||||
Cash And Equivalents | 32.36 M | ||||
Cash Per Share | 0.55 X | ||||
Total Debt | 423 K | ||||
Debt To Equity | 0.02 % | ||||
Current Ratio | 10.42 X | ||||
Book Value Per Share | 0.37 X | ||||
Cash Flow From Operations | (28.45 M) | ||||
Short Ratio | 3.41 X | ||||
Earnings Per Share | (0.30) X | ||||
Target Price | 4.86 | ||||
Beta | 1.46 | ||||
Market Capitalization | 84.47 M | ||||
Total Asset | 38.82 M | ||||
Retained Earnings | (446 M) | ||||
Working Capital | 33.94 M | ||||
Current Asset | 14.39 M | ||||
Current Liabilities | 2.91 M | ||||
Net Asset | 38.82 M |
About Oncolytics Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oncolytics Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oncolytics Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oncolytics Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Oncolytics Biotech Piotroski F Score and Oncolytics Biotech Altman Z Score analysis. For more information on how to buy Oncolytics Stock please use our How to Invest in Oncolytics Biotech guide.Note that the Oncolytics Biotech information on this page should be used as a complementary analysis to other Oncolytics Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Oncolytics Stock analysis
When running Oncolytics Biotech's price analysis, check to measure Oncolytics Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncolytics Biotech is operating at the current time. Most of Oncolytics Biotech's value examination focuses on studying past and present price action to predict the probability of Oncolytics Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncolytics Biotech's price. Additionally, you may evaluate how the addition of Oncolytics Biotech to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Oncolytics Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncolytics Biotech. If investors know Oncolytics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncolytics Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.30) | Return On Assets (0.55) | Return On Equity (1.03) |
The market value of Oncolytics Biotech is measured differently than its book value, which is the value of Oncolytics that is recorded on the company's balance sheet. Investors also form their own opinion of Oncolytics Biotech's value that differs from its market value or its book value, called intrinsic value, which is Oncolytics Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncolytics Biotech's market value can be influenced by many factors that don't directly affect Oncolytics Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncolytics Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncolytics Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncolytics Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.